Combination Treatment of Human Pancreatic Cancer Xenograft Models with the Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Erlotinib and Oncolytic Herpes Simplex Virus HF10
出版年份 2013 全文链接
标题
Combination Treatment of Human Pancreatic Cancer Xenograft Models with the Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Erlotinib and Oncolytic Herpes Simplex Virus HF10
作者
关键词
Pancreatic Cancer, Erlotinib, Interstitial Fluid Pressure, Combination Therapy Group, Dulbecco Modify Eagle Medium
出版物
ANNALS OF SURGICAL ONCOLOGY
Volume 21, Issue 2, Pages 691-698
出版商
Springer Nature
发表日期
2013-10-30
DOI
10.1245/s10434-013-3329-3
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The reduction of tumor interstitial fluid pressure by liposomal imatinib and its effect on combination therapy with liposomal doxorubicin
- (2013) Yuchen Fan et al. BIOMATERIALS
- Impact of novel oncolytic virus HF10 on cellular components of the tumor microenviroment in patients with recurrent breast cancer
- (2011) T T Sahin et al. CANCER GENE THERAPY
- A phase I dose-escalation clinical trial of intraoperative direct intratumoral injection of HF10 oncolytic virus in non-resectable patients with advanced pancreatic cancer
- (2010) A Nakao et al. CANCER GENE THERAPY
- Impact of tumor microenvironment on oncolytic viral therapy
- (2010) Jeffrey Wojton et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Gemcitabine Plus Bevacizumab Compared With Gemcitabine Plus Placebo in Patients With Advanced Pancreatic Cancer: Phase III Trial of the Cancer and Leukemia Group B (CALGB 80303)
- (2010) Hedy Lee Kindler et al. JOURNAL OF CLINICAL ONCOLOGY
- Hyaluronidase Expression by an Oncolytic Adenovirus Enhances Its Intratumoral Spread and Suppresses Tumor Growth
- (2010) Sonia Guedan et al. MOLECULAR THERAPY
- HSV immune complex (HSV-IgG: IC) and HSV-DNA elicit the production of angiogenic factor VEGF and MMP-9
- (2009) Kozaburo Hayashi et al. ARCHIVES OF VIROLOGY
- VEGF-A expression by HSV-1–infected cells drives corneal lymphangiogenesis
- (2009) Todd R. Wuest et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Enhanced Antitumor Efficacy of Vasculostatin (Vstat120) Expressing Oncolytic HSV-1
- (2009) Jayson Hardcastle et al. MOLECULAR THERAPY
- Targeted Delivery of Gemcitabine to Pancreatic Adenocarcinoma Using Cetuximab as a Targeting Agent
- (2008) C. R. Patra et al. CANCER RESEARCH
- Bevacizumab Increases Viral Distribution in Human Anaplastic Thyroid Carcinoma Xenografts and Enhances the Effects of E1A-Defective Adenovirus dl922-947
- (2008) S. Libertini et al. CLINICAL CANCER RESEARCH
- Intratumoral Coadministration of Hyaluronidase Enzyme and Oncolytic Adenoviruses Enhances Virus Potency in Metastatic Tumor Models
- (2008) S. Ganesh et al. CLINICAL CANCER RESEARCH
- Non-Engineered, Naturally Oncolytic Herpes Simplex Virus HSV1 HF-10:Applications for Cancer Gene Therapy
- (2008) Akihiro Nawa et al. CURRENT GENE THERAPY
- Oncolytic virotherapy for malignant melanoma with herpes simplex virus type 1 mutant HF10
- (2008) Daisuke Watanabe et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Oncolytic HSV-1 Infection of Tumors Induces Angiogenesis and Upregulates CYR61
- (2008) Kazuhiko Kurozumi et al. MOLECULAR THERAPY
- Bevacizumab and Erlotinib: A Promising New Approach to the Treatment of Advanced NSCLC
- (2008) R. S. Herbst et al. ONCOLOGIST
- Changes in pancreatic cancer mortality, period patterns, and birth cohort patterns in Japan: analysis of mortality data in the period 1968–2002
- (2008) Takayuki Seino et al. Environmental Health and Preventive Medicine
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started